Cargando…

Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development

This review provides an overview of the properties of cyclotides and their potential for developing novel peptide-based therapeutics. The selective disruption of protein–protein interactions remains challenging, as the interacting surfaces are relatively large and flat. However, highly constrained p...

Descripción completa

Detalles Bibliográficos
Autores principales: Jacob, Binu, Vogelaar, Alicia, Cadenas, Enrique, Camarero, Julio A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570680/
https://www.ncbi.nlm.nih.gov/pubmed/36234971
http://dx.doi.org/10.3390/molecules27196430
_version_ 1784810170513096704
author Jacob, Binu
Vogelaar, Alicia
Cadenas, Enrique
Camarero, Julio A.
author_facet Jacob, Binu
Vogelaar, Alicia
Cadenas, Enrique
Camarero, Julio A.
author_sort Jacob, Binu
collection PubMed
description This review provides an overview of the properties of cyclotides and their potential for developing novel peptide-based therapeutics. The selective disruption of protein–protein interactions remains challenging, as the interacting surfaces are relatively large and flat. However, highly constrained polypeptide-based molecular frameworks with cell-permeability properties, such as the cyclotide scaffold, have shown great promise for targeting those biomolecular interactions. The use of molecular techniques, such as epitope grafting and molecular evolution employing the cyclotide scaffold, has shown to be highly effective for selecting bioactive cyclotides.
format Online
Article
Text
id pubmed-9570680
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95706802022-10-17 Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development Jacob, Binu Vogelaar, Alicia Cadenas, Enrique Camarero, Julio A. Molecules Review This review provides an overview of the properties of cyclotides and their potential for developing novel peptide-based therapeutics. The selective disruption of protein–protein interactions remains challenging, as the interacting surfaces are relatively large and flat. However, highly constrained polypeptide-based molecular frameworks with cell-permeability properties, such as the cyclotide scaffold, have shown great promise for targeting those biomolecular interactions. The use of molecular techniques, such as epitope grafting and molecular evolution employing the cyclotide scaffold, has shown to be highly effective for selecting bioactive cyclotides. MDPI 2022-09-29 /pmc/articles/PMC9570680/ /pubmed/36234971 http://dx.doi.org/10.3390/molecules27196430 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Jacob, Binu
Vogelaar, Alicia
Cadenas, Enrique
Camarero, Julio A.
Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development
title Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development
title_full Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development
title_fullStr Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development
title_full_unstemmed Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development
title_short Using the Cyclotide Scaffold for Targeting Biomolecular Interactions in Drug Development
title_sort using the cyclotide scaffold for targeting biomolecular interactions in drug development
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570680/
https://www.ncbi.nlm.nih.gov/pubmed/36234971
http://dx.doi.org/10.3390/molecules27196430
work_keys_str_mv AT jacobbinu usingthecyclotidescaffoldfortargetingbiomolecularinteractionsindrugdevelopment
AT vogelaaralicia usingthecyclotidescaffoldfortargetingbiomolecularinteractionsindrugdevelopment
AT cadenasenrique usingthecyclotidescaffoldfortargetingbiomolecularinteractionsindrugdevelopment
AT camarerojulioa usingthecyclotidescaffoldfortargetingbiomolecularinteractionsindrugdevelopment